The bovine diagnostics market size is expected to reach US$ 2,011.15 million by 2030 from US$ 1,155.59 million in 2022; it is estimated to record a CAGR of 7.2% from 2022 to 2030.
Continuous research and development efforts allow veterinary diagnostics companies to launch various innovative diagnostics products that provide rapid results. In addition, growing awareness among end users through the government’s educative and knowledge-sharing programs has encouraged these companies to introduce advanced diagnostics products. A few of the recent product launches in the bovine diagnostics market have been mentioned below.
•In June 2023, Zoetis, Inc. launched Vetscan Mastigram+, an on-farm mastitis diagnostic solution that provides results 8 hours before the next milking. The Vetsacn Mastigram+ uses a flow dipstick test to detect Gram-positive mastitis in cattle. The product would detect the presence of Gram-positive pathogens in cow milk with 99% sensitivity and 100% specificity, along with differentiating between for Gram-positive and Gram-negative bacteria.
•In June 2023, Neogen Corporation launched Igenity^ BeefXDairy, a DNA test for beef-on-dairy cattle. The test would provide insights into the traits such as carcass quality, average daily gain, and the Igenity Terminal Index to the producers. In addition, it would allow buyers to receive breed composition data to help them with optimal cattle health management and maximize the cattle product yield.
•In August 2023, Biotangents, a Scottish biotech company, announced the launch of its next-generation molecular diagnostic assay—AmpliSpec LAB Mastitis. The company claims that AmpliSpec LAB Mastitis is a highly sophisticated assay with 93% sensitivity and 95% specificity in detecting mastitis pathogens in dairy cows.
Increasing incidences of foot and mouth diseases are likely to boost the growth of bovine diagnostics market
In livestock, foot and mouth disease (FMD) is a highly contagious viral disease that has a significant economic impact. It affects cattle, swine, sheep, goats, and other cloven-hoofed ruminants. The disease is a transboundary animal disease (TAD) that disrupts the trade of animals and animal products in regional and global markets. According to the World Organization for Animal Health, 77% population of livestock is estimated to be infected with the disease across the world, primarily in Africa, the Middle East, and Asia, as well as a limited area of South America. A total of 75% of FMD prevention and control costs are provided by countries with low incomes and lower middle incomes. Approximately 50% of the total costs are incurred by Africa and Eurasia. Seven strains of an Aphthovirus (A, O, C, SAT1, SAT2, SAT3, and Asia1) are endemic in different parts of the world. The prevention of FMD is based on early detection and warning systems, effective surveillance, and other measures. Each strain requires a specific vaccine to provide immunity to a vaccinated animal.
Most common FMD diagnostic techniques are infection-associated antigen (VIA), complement fixation (CF), ELISA, and PCR tests to detect FMD viral antigen, virus isolation, and neutralization. IDEXX offers IDEXX FMD 3 ABC Ab Test Kit, an enzyme immunoassay for the detection of antibodies against FMDV in serum or plasma samples of bovine origin.
Thus, aforementioned factors propel the bovine diagnostics market growth for the foot and mouth disease segment.
The “Global Bovine Diagnostics Market” is segmented based on product, disease type, and end user.
By product, the bovine diagnostics market is bifurcated into immunoassay kits, PCR kits, hemagglutination inhibition (HI) assay, and others. The immunoassay kits segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022–2030.
Based on disease type, the market is categorized into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and others. The bovine mastitis segment held a larger market share in 2022 and the segment is anticipated to register a higher CAGR during 2022–2030.
Based on end user, the bovine diagnostics market is divided into veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR during 2022–2030.
Major players operating in the bovine diagnostics market are Idexx Laboratories Inc, PBD Biotech Ltd, Thermo Fisher Scientific Inc, Innovative Diagnostics SAS, Neogen Corp, Enfer Labs, bioMerieux SA, Ring Biotechnology Co Ltd, Bionote Inc, and Shenzhen Bioeasy Biotechnology Co Ltd.
The American Association for Thoracic Surgery (AATS), Centers for Disease Control and Prevention (CDC), National Institute for Health and Care Excellence (NICE), Organisation for Economic Co-operation and Development (OECD), and Spanish National Health System (SNS) among others are a few key primary and secondary sources referred to while preparing the report on the bovine diagnostics market.